Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5274545
Max Phase: Preclinical
Molecular Formula: C38H54Br2N4O4
Molecular Weight: 630.87
Associated Items:
ID: ALA5274545
Max Phase: Preclinical
Molecular Formula: C38H54Br2N4O4
Molecular Weight: 630.87
Associated Items:
Canonical SMILES: CC[C@@H]1C(=O)OC[C@@H]1Cc1c[n+](CCCCCCCC[N+](C)(C)CC(C)(C)CN2C(=O)c3cccc4cccc(c34)C2=O)cn1C.[Br-].[Br-]
Standard InChI: InChI=1S/C38H54N4O4.2BrH/c1-7-31-29(24-46-37(31)45)22-30-23-40(27-39(30)4)20-12-10-8-9-11-13-21-42(5,6)26-38(2,3)25-41-35(43)32-18-14-16-28-17-15-19-33(34(28)32)36(41)44;;/h14-19,23,27,29,31H,7-13,20-22,24-26H2,1-6H3;2*1H/q+2;;/p-2/t29-,31-;;/m0../s1
Standard InChI Key: NKTPWCHACNCAGN-OWNZYUDVSA-L
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 630.87 | Molecular Weight (Monoisotopic): 630.4134 | AlogP: 5.95 | #Rotatable Bonds: 16 |
Polar Surface Area: 72.49 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 0 |
#RO5 Violations: 2 | HBA (Lipinski): 8 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: -1.62 | CX LogD: -1.62 |
Aromatic Rings: 3 | Heavy Atoms: 46 | QED Weighted: 0.06 | Np Likeness Score: 0.49 |
1. Heinz CS, Bermudez M, Jaiswal N, Große C, Kauk M, Hoffmann C, Holzgrabe U.. (2023) Hybridization into a Bitopic Ligand Increased Muscarinic Receptor Activation for Isopilocarpine but Not for Pilocarpine Derivatives., 86 (4): [PMID:37042802] [10.1021/acs.jnatprod.2c01079] |
Source(1):